Abstract
OncomiRNAs (oncomiRs) are small regulatory microRNAs (miRNAs) that play an important role in tumor formation and progression. These oncomiRs are found to regulate different types of tumor by targeting a large set of cancer driver genes (including oncogenes and tumor suppressor genes). In the present work, we have developed a pipeline for the identification of frequently occurring and clinically relevant driver genes in pan-negative melanoma (absence of mutations in BRAF (affecting V600), NRAS (G12, G13, and Q61), KIT (W557, V559, L576, K642, D816), GNAQ (Q209), and GNA11 (Q209) by integrating oncomiRs regulated genes and frequently mutated genes in melanoma pan-negative samples. The preliminary experience has identified 28 potential driver genes that are regulated by oncomiRs, of which 25 genes are associated with drugs, 3 differentially expressed genes are associated with metastasis. This analysis provides a method to mine clinically relevant driver genes in pan-negative melanomas.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Xie, B., et al.: Mircancer: A Microrna–Cancer Association Database Constructed by Text Mining on Literature. Bioinformatics 29(5), 638–644 (2013)
Ruepp, A., Kowarsch, Theis, F.: Phenomir: Micrornas in Human Diseases and Biological Processes. In: Next-Generation Microrna Expression Profiling Technology, pp. 249–260. Springer (2012)
Bhattacharya, A., Ziebarth, J.D., Cui, Y.: Somamir: A Database for Somatic Mutations Impacting Microrna Function in Cancer. Nucleic Acids Research 41(D1), D977–D982 (2013)
Wang, D., et al.: Oncomirdb: A Database for The Experimentally Verified Oncogenic and Tumor-Suppressive Micrornas. Bioinformatics, Btu155 (2014), doi:10.1093/Bioinformatics/Btu155
Siegel, R., et al.: Cancer Statistics. CA: A Cancer Journal for Clinicians 64(1), 9–29 (2014)
Xia, J., et al.: A Meta-Analysis of Somatic Mutations From Next Generation Sequencing of 241 Melanomas: A Road Map for The Study of Genes With Potential Clinical Relevance. Molecular Cancer Therapeutics, Molcanther. 0804.2013 (2014), doi:10.1158/1535-7163.MCT-13-0804
Hsu, S.-D., et al.: Mirtarbase Update 2014: An Information Resource for Experimentally Validated Mirna-Target Interactions. Nucleic Acids Research 42(D1), D78–D85 (2014)
Trevarton, A.J., et al.: Melanomadb: A Web Tool for Integrative Analysis of Melanoma Genomic Information to Identify Disease-Associated Molecular Pathways. Frontiers in Oncology 3 (2013), doi:10.3389/Fonc.2013.00184
Dennis Jr., G., et al.: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome. Biol. 4(5), P3 (2003)
Yang, H., et al.: RG7204 (PLX4032), A Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models. Cancer Research 70(13), 5518–5527 (2010)
Weiss, A., Attisano, L.: The Tgfbeta Superfamily Signaling Pathway. Wiley Interdisciplinary Reviews: Developmental Biology 2(1), 47–63 (2013)
Egawa, T., et al.: Requirement for CARMA1 in Antigen Receptor-Induced NF-KB Activation and Lymphocyte Proliferation. Current Biology 13(14), 1252–1258 (2003)
Ueda, T., et al.: Relation between Microrna Expression and Progression and Prognosis of Gastric Cancer: A Microrna Expression Analysis. The Lancet Oncology 11(2), 136–146 (2010)
Smirnov, D.A., et al.: Global Gene Expression Profiling of Circulating Endothelial Cells in Patients With Metastatic Carcinomas. Cancer Research 66(6), 2918–2922 (2006)
Lerebours, F., et al.: NF-Kappa B Genes Have A Major Role in Inflammatory Breast Cancer. BMC Cancer 8(1), 41 (2008)
Ma, X.-J., et al.: Gene Expression Profiling of The Tumor Microenvironment During Breast Cancer Progression. Breast Cancer Res. 11(1), R7 (2009)
Massion, P., et al.: Recurrent Genomic Gains in Preinvasive Lesions As A Biomarker of Risk for Lung Cancer. Plos One 4(6), E5611 (2009)
Zhu, D., et al.: Amplification and Overexpression of TP63 and MYC As Biomarkers for Transition of Cervical Intraepithelial Neoplasia to Cervical Cancer. International Journal of Gynecological Cancer 24(4), 643–648 (2014)
Fox, M.D., et al.: Cutaneous Meningioma: A Potential Diagnostic Pitfall in P63 Positive Cutaneous Neoplasms. Journal of Cutaneous Pathology 40(10), 891–895 (2013)
Hibi, K., et al.: AIS Is An Oncogene Amplified in Squamous Cell Carcinoma. Proceedings of the National Academy of Sciences 97(10), 5462–5467 (2000)
Zetter, B.: Adhesion Molecules in Tumor Metastasis. Seminars in Cancer Biology 4(4), 219–229 (1993)
Meyer, T., Hart, I.: Mechanisms of Tumour Metastasis. European Journal of Cancer 34(2), 214–221 (1998)
O’hanlon, D., et al.: Soluble Adhesion Molecules (E-Selectin, ICAM-1 and VCAM-1) in Breast Carcinoma. European Journal of Cancer 38(17), 2252–2257 (2002)
Gogali, A., et al.: Soluble Adhesion Molecules E-Cadherin, Intercellular Adhesion Molecule-1, and E-Selectin As Lung Cancer Biomarkers. CHEST Journal 138(5), 1173–1179 (2010)
Kobayashi, K.-I., et al.: Cimetidine Inhibits Cancer Cell Adhesion to Endothelial Cells and Prevents Metastasis by Blocking E-Selectin Expression. Cancer Research 60(14), 3978–3984 (2000)
Xu, L., et al.: Gene Expression Changes in An Animal Melanoma Model Correlate With Aggressiveness of Human Melanoma Metastases. Molecular Cancer Research 6(5), 760–769 (2008)
Odorisio, T., et al.: Monozygotic Twins Discordant for Recessive Dystrophic Epidermolysis Bullosa Phenotype Highlight The Role of TGF-B Signalling in Modifying Disease Severity. Human Molecular Genetics, Ddu102 (2014), doi:10.1093/Hmg/Ddu102
Madan, V., Lear, J.T., Szeimies, R.-M.: Non-Melanoma Skin Cancer. The Lancet 375(9715), 673–685 (2010)
Jin, L., et al.: Differential Secretome Analysis Reveals CST6 As A Suppressor of Breast Cancer Bone Metastasis. Cell Research 22(9), 1356–1373 (2012)
Pourreyron, C., et al.: High Levels of Type VII Collagen Expression in RDEB Cscc Keratinocytes Increases PI3K and MAPK Signalling, Cell Migration and Invasion. British Journal of Dermatology (2013), doi:10.1111/Bjd.12715
Hosgood III, H.D., et al.: Genetic Variant in TP63 on Locus 3q28 Is Associated With Risk of Lung Adenocarcinoma Among Never-Smoking Females in Asia. Human Genetics 131(7), 1197–1203 (2012)
Alexiou, D., et al.: Serum Levels of E-Selectin, ICAM-1 and VCAM-1 in Colorectal Cancer Patients: Correlations With Clinicopathological Features, Patient Survival and Tumour Surgery. European Journal of Cancer 37(18), 2392–2397 (2001)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this paper
Cite this paper
Zhang, D., Xia, J. (2014). Potential Driver Genes Regulated by OncomiRNA Are Associated with Druggability in Pan-Negative Melanoma. In: Huang, DS., Han, K., Gromiha, M. (eds) Intelligent Computing in Bioinformatics. ICIC 2014. Lecture Notes in Computer Science(), vol 8590. Springer, Cham. https://doi.org/10.1007/978-3-319-09330-7_38
Download citation
DOI: https://doi.org/10.1007/978-3-319-09330-7_38
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09329-1
Online ISBN: 978-3-319-09330-7
eBook Packages: Computer ScienceComputer Science (R0)